FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377012767> ?p ?o ?g. }

• W4377012767 endingPage "e33638" @default.
• W4377012767 startingPage "e33638" @default.
• W4377012767 abstract "Administration of pegylated granulocyte-colony-stimulating factor (peg-GCSF) 24 to 72 hours after chemotherapy is usually recommended. Next-day administration (after 24 hours) resulted in fewer duration of grade (Gr) 4 chemotherapy-induced neutropenia (CIN) and decreased severity of CIN than same-day (within 4 hours). However, patients sometimes receive same-day Peg-GCSF for the sake of convenience. In addition, a few prior studies showed that the same-day method is comparable or superior to the next-day method in preventing CIN, especially in chemotherapy regimens that include day 1 myelosuppressive agents. Thus, we aim to verify the hypothesis that same-day administration of pegteograstim, a new formulation of peg-GCSF, is non-inferior to next-day administration in terms of Gr4 CIN duration.This study is a randomized, multicenter, open-label, investigator-initiated phase 3 study. Patients with adjuvant/neoadjuvant or first-line palliative chemotherapy comprising intensively myelosuppressive agents on day 1 (mFOLFIRINOX, ECb, EP, FOLFIRI, and FOLFOX) are enrolled. The patients are assigned to the same-day arm or the next-day arm in a 1:1 ratio. The randomizations are stratified according to number of patient CIN risk factors (1 vs ≥2), chemotherapy setting (perioperative vs palliative), and interval (2-week vs 3-week). In the same-day arm, pegteograstim 6 mg is subcutaneously injected within 4 hours after completion of chemotherapy. In the next-day arm, pegetograstim is injected at 24 to 36 hours post-chemotherapy. A complete blood count test is performed daily from day 5 to 9 during the cycle 1. The primary endpoint is duration of Gr4 CIN (cycle 1), and secondary endpoints include incidence of Gr 3 to 4 CIN (cycle 1), severity of CIN (cycle 1), time to recovery absolute neutrophil count 1000/μL (cycle 1), incidence of febrile neutropenia, incidence of CIN-related dose delay, and dose intensity. In order to verify non-inferiority of 0.6 days, we estimated a significance level of 5%, power of 80%, and drop-out rate of 15%. This results in the need for a total of 160 patients, 80 in each group." @default.
• W4377012767 created "2023-05-19" @default.
• W4377012767 creator A5003219699 @default.
• W4377012767 creator A5008493307 @default.
• W4377012767 creator A5010509952 @default.
• W4377012767 creator A5012978943 @default.
• W4377012767 creator A5013690275 @default.
• W4377012767 creator A5014103481 @default.
• W4377012767 creator A5026081443 @default.
• W4377012767 creator A5030219026 @default.
• W4377012767 creator A5059849795 @default.
• W4377012767 creator A5079154981 @default.
• W4377012767 creator A5079616603 @default.
• W4377012767 date "2023-05-19" @default.
• W4377012767 modified "2023-09-30" @default.
• W4377012767 title "Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial" @default.
• W4377012767 cites W2037732945 @default.
• W4377012767 cites W2083336892 @default.
• W4377012767 cites W2100082529 @default.
• W4377012767 cites W2110645520 @default.
• W4377012767 cites W2121985645 @default.
• W4377012767 cites W2127713365 @default.
• W4377012767 cites W2175192019 @default.
• W4377012767 cites W2336901813 @default.
• W4377012767 cites W2810000146 @default.
• W4377012767 cites W2999700331 @default.
• W4377012767 doi "https://doi.org/10.1097/md.0000000000033638" @default.
• W4377012767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37335745" @default.
• W4377012767 hasPublicationYear "2023" @default.
• W4377012767 type Work @default.
• W4377012767 citedByCount "0" @default.
• W4377012767 crossrefType "journal-article" @default.
• W4377012767 hasAuthorship W4377012767A5003219699 @default.
• W4377012767 hasAuthorship W4377012767A5008493307 @default.
• W4377012767 hasAuthorship W4377012767A5010509952 @default.
• W4377012767 hasAuthorship W4377012767A5012978943 @default.
• W4377012767 hasAuthorship W4377012767A5013690275 @default.
• W4377012767 hasAuthorship W4377012767A5014103481 @default.
• W4377012767 hasAuthorship W4377012767A5026081443 @default.
• W4377012767 hasAuthorship W4377012767A5030219026 @default.
• W4377012767 hasAuthorship W4377012767A5059849795 @default.
• W4377012767 hasAuthorship W4377012767A5079154981 @default.
• W4377012767 hasAuthorship W4377012767A5079616603 @default.
• W4377012767 hasBestOaLocation W43770127671 @default.
• W4377012767 hasConcept C126322002 @default.
• W4377012767 hasConcept C141071460 @default.
• W4377012767 hasConcept C2776694085 @default.
• W4377012767 hasConcept C2777063308 @default.
• W4377012767 hasConcept C2777767877 @default.
• W4377012767 hasConcept C2778336483 @default.
• W4377012767 hasConcept C2781413609 @default.
• W4377012767 hasConcept C71924100 @default.
• W4377012767 hasConceptScore W4377012767C126322002 @default.
• W4377012767 hasConceptScore W4377012767C141071460 @default.
• W4377012767 hasConceptScore W4377012767C2776694085 @default.
• W4377012767 hasConceptScore W4377012767C2777063308 @default.
• W4377012767 hasConceptScore W4377012767C2777767877 @default.
• W4377012767 hasConceptScore W4377012767C2778336483 @default.
• W4377012767 hasConceptScore W4377012767C2781413609 @default.
• W4377012767 hasConceptScore W4377012767C71924100 @default.
• W4377012767 hasIssue "20" @default.
• W4377012767 hasLocation W43770127671 @default.
• W4377012767 hasLocation W43770127672 @default.
• W4377012767 hasLocation W43770127673 @default.
• W4377012767 hasLocation W43770127674 @default.
• W4377012767 hasOpenAccess W4377012767 @default.
• W4377012767 hasPrimaryLocation W43770127671 @default.
• W4377012767 hasRelatedWork W136411592 @default.
• W4377012767 hasRelatedWork W2017298652 @default.
• W4377012767 hasRelatedWork W2020898191 @default.
• W4377012767 hasRelatedWork W2049364475 @default.
• W4377012767 hasRelatedWork W2061928026 @default.
• W4377012767 hasRelatedWork W2114989931 @default.
• W4377012767 hasRelatedWork W2120457371 @default.
• W4377012767 hasRelatedWork W2366109111 @default.
• W4377012767 hasRelatedWork W2418276413 @default.
• W4377012767 hasRelatedWork W2472158911 @default.
• W4377012767 hasVolume "102" @default.
• W4377012767 isParatext "false" @default.
• W4377012767 isRetracted "false" @default.
• W4377012767 workType "article" @default.